Do analysts recommend POAI or XAIR?

Beyond Air has a consensus target price of $10.00, indicating a potential upside of 2,036.75%. Given Beyond Air's stronger consensus rating and higher possible upside, analysts clearly believe Beyond Air is more favorable than Predictive Oncology. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Predictive Oncology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Beyond Air 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Do analysts recommend XAIR or MODD?

Beyond Air presently has a consensus target price of $10.00, suggesting a potential upside of 2,036.75%. Given Beyond Air's stronger consensus rating and higher probable upside, research analysts clearly believe Beyond Air is more favorable than Modular Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Beyond Air 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Modular Medical 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is XAIR or MODD more profitable?

Modular Medical has a net margin of 0.00% compared to Beyond Air's net margin of -432.99%. Modular Medical's return on equity of -245.85% beat Beyond Air's return on equity. Company Net Margins Return on Equity Return on Assets Beyond Air -432.99% -350.00% -101.34% Modular Medical N/A -245.85% -190.80%

Which has better valuation & earnings, IRIX or XAIR?

IRIDEX has higher revenue and earnings than Beyond Air. IRIDEX is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio IRIDEX $52.67M 0.37 -$4.44M -$0.19 N/A Beyond Air $7.68M 0.88 -$33.25M -$4.40 N/A

Is IRIX or XAIR more profitable?

IRIDEX has a net margin of -6.23% compared to Beyond Air's net margin of -432.99%. IRIDEX's return on equity of 0.00% beat Beyond Air's return on equity. Company Net Margins Return on Equity Return on Assets IRIDEX -6.23% N/A -11.16% Beyond Air -432.99% -350.00% -101.34%

Do analysts prefer RVP or XAIR?

Beyond Air has a consensus price target of $10.00, suggesting a potential upside of 2,036.75%. Given Beyond Air's stronger consensus rating and higher probable upside, analysts clearly believe Beyond Air is more favorable than Retractable Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Retractable Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Beyond Air 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Beyond Air (XAIR) Competitors

$0.47 0.00 (0.00%)

Closing price 07/2/2026 04:00 PM Eastern

Extended Trading

$0.45 -0.02 (-3.85%)

As of 07/2/2026 07:22 PM Eastern

Compare

XAIR vs. MLSS, POAI, MODD, IRIX, and RVP

Should you buy Beyond Air stock or one of its competitors? MarketBeat compares Beyond Air with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Beyond Air include Milestone Scientific (MLSS), Predictive Oncology (POAI), Modular Medical (MODD), IRIDEX (IRIX), and Retractable Technologies (RVP). These companies are all part of the "medical equipment" industry.

How does Beyond Air compare to Milestone Scientific?

Beyond Air (NASDAQ:XAIR) and Milestone Scientific (NYSE:MLSS) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, media sentiment, institutional ownership, risk, profitability, analyst recommendations and dividends.

Milestone Scientific has a net margin of -52.01% compared to Beyond Air's net margin of -432.99%. Milestone Scientific's return on equity of -60.26% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beyond Air	-432.99%	-350.00%	-101.34%
Milestone Scientific	-52.01%	-60.26%	-40.23%

31.5% of Beyond Air shares are owned by institutional investors. Comparatively, 5.8% of Milestone Scientific shares are owned by institutional investors. 10.0% of Beyond Air shares are owned by insiders. Comparatively, 9.2% of Milestone Scientific shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Milestone Scientific has higher revenue and earnings than Beyond Air. Milestone Scientific is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beyond Air	$7.68M	0.88	-$33.25M	-$4.40	N/A
Milestone Scientific	$8.90M	3.40	-$6.93M	-$0.05	N/A

Beyond Air has a beta of 0.22, meaning that its share price is 78% less volatile than the broader market. Comparatively, Milestone Scientific has a beta of 1.05, meaning that its share price is 5% more volatile than the broader market.

Beyond Air currently has a consensus price target of $10.00, indicating a potential upside of 2,036.75%. Milestone Scientific has a consensus price target of $1.00, indicating a potential upside of 192.14%. Given Beyond Air's higher possible upside, analysts clearly believe Beyond Air is more favorable than Milestone Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Milestone Scientific	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

In the previous week, Milestone Scientific had 2 more articles in the media than Beyond Air. MarketBeat recorded 2 mentions for Milestone Scientific and 0 mentions for Beyond Air. Beyond Air's average media sentiment score of 0.00 equaled Milestone Scientific'saverage media sentiment score.

Company	Overall Sentiment
Beyond Air	Neutral
Milestone Scientific	Neutral

Summary

Milestone Scientific beats Beyond Air on 10 of the 15 factors compared between the two stocks.

How does Beyond Air compare to Predictive Oncology?

Predictive Oncology (NASDAQ:POAI) and Beyond Air (NASDAQ:XAIR) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, media sentiment, valuation, dividends, profitability, risk and analyst recommendations.

Predictive Oncology has higher earnings, but lower revenue than Beyond Air. Predictive Oncology is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Predictive Oncology	$1.66M	14.44	-$12.66M	-$13.50	N/A
Beyond Air	$7.68M	0.88	-$33.25M	-$4.40	N/A

In the previous week, Predictive Oncology's average media sentiment score of 0.00 equaled Beyond Air'saverage media sentiment score.

Company	Overall Sentiment
Predictive Oncology	Neutral
Beyond Air	Neutral

Predictive Oncology has a beta of 1.35, suggesting that its stock price is 35% more volatile than the broader market. Comparatively, Beyond Air has a beta of 0.22, suggesting that its stock price is 78% less volatile than the broader market.

Beyond Air has a consensus target price of $10.00, indicating a potential upside of 2,036.75%. Given Beyond Air's stronger consensus rating and higher possible upside, analysts clearly believe Beyond Air is more favorable than Predictive Oncology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Predictive Oncology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Beyond Air has a net margin of -432.99% compared to Predictive Oncology's net margin of -5,065.23%. Beyond Air's return on equity of -350.00% beat Predictive Oncology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Predictive Oncology	-5,065.23%	-732.73%	-235.55%
Beyond Air	-432.99%	-350.00%	-101.34%

9.0% of Predictive Oncology shares are owned by institutional investors. Comparatively, 31.5% of Beyond Air shares are owned by institutional investors. 1.2% of Predictive Oncology shares are owned by company insiders. Comparatively, 10.0% of Beyond Air shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Beyond Air beats Predictive Oncology on 11 of the 14 factors compared between the two stocks.

How does Beyond Air compare to Modular Medical?

Beyond Air (NASDAQ:XAIR) and Modular Medical (NASDAQ:MODD) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, media sentiment, profitability, institutional ownership, analyst recommendations and risk.

31.5% of Beyond Air shares are held by institutional investors. Comparatively, 27.5% of Modular Medical shares are held by institutional investors. 10.0% of Beyond Air shares are held by insiders. Comparatively, 7.1% of Modular Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Beyond Air has a beta of 0.22, indicating that its share price is 78% less volatile than the broader market. Comparatively, Modular Medical has a beta of 0.32, indicating that its share price is 68% less volatile than the broader market.

Modular Medical has a net margin of 0.00% compared to Beyond Air's net margin of -432.99%. Modular Medical's return on equity of -245.85% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beyond Air	-432.99%	-350.00%	-101.34%
Modular Medical	N/A	-245.85%	-190.80%

In the previous week, Modular Medical had 2 more articles in the media than Beyond Air. MarketBeat recorded 2 mentions for Modular Medical and 0 mentions for Beyond Air. Beyond Air's average media sentiment score of 0.00 equaled Modular Medical'saverage media sentiment score.

Company	Overall Sentiment
Beyond Air	Neutral
Modular Medical	Neutral

Beyond Air presently has a consensus target price of $10.00, suggesting a potential upside of 2,036.75%. Given Beyond Air's stronger consensus rating and higher probable upside, research analysts clearly believe Beyond Air is more favorable than Modular Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Modular Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Modular Medical has lower revenue, but higher earnings than Beyond Air. Modular Medical is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beyond Air	$7.68M	0.88	-$33.25M	-$4.40	N/A
Modular Medical	N/A	N/A	-$18.82M	-$14.71	N/A

Summary

Beyond Air beats Modular Medical on 9 of the 14 factors compared between the two stocks.

How does Beyond Air compare to IRIDEX?

IRIDEX (NASDAQ:IRIX) and Beyond Air (NASDAQ:XAIR) are both small-cap medical equipment companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, risk, institutional ownership, media sentiment, valuation, dividends and profitability.

IRIDEX has a net margin of -6.23% compared to Beyond Air's net margin of -432.99%. IRIDEX's return on equity of 0.00% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IRIDEX	-6.23%	N/A	-11.16%
Beyond Air	-432.99%	-350.00%	-101.34%

IRIDEX presently has a consensus price target of $3.00, suggesting a potential upside of 165.49%. Beyond Air has a consensus price target of $10.00, suggesting a potential upside of 2,036.75%. Given Beyond Air's stronger consensus rating and higher possible upside, analysts clearly believe Beyond Air is more favorable than IRIDEX.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

IRIDEX has higher revenue and earnings than Beyond Air. IRIDEX is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IRIDEX	$52.67M	0.37	-$4.44M	-$0.19	N/A
Beyond Air	$7.68M	0.88	-$33.25M	-$4.40	N/A

20.1% of IRIDEX shares are held by institutional investors. Comparatively, 31.5% of Beyond Air shares are held by institutional investors. 8.6% of IRIDEX shares are held by insiders. Comparatively, 10.0% of Beyond Air shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

IRIDEX has a beta of 0.63, meaning that its stock price is 37% less volatile than the broader market. Comparatively, Beyond Air has a beta of 0.22, meaning that its stock price is 78% less volatile than the broader market.

In the previous week, IRIDEX had 1 more articles in the media than Beyond Air. MarketBeat recorded 1 mentions for IRIDEX and 0 mentions for Beyond Air. IRIDEX's average media sentiment score of 0.75 beat Beyond Air's score of 0.00 indicating that IRIDEX is being referred to more favorably in the media.

Company	Overall Sentiment
IRIDEX	Positive
Beyond Air	Neutral

Summary

IRIDEX beats Beyond Air on 9 of the 16 factors compared between the two stocks.

How does Beyond Air compare to Retractable Technologies?

Retractable Technologies (NYSE:RVP) and Beyond Air (NASDAQ:XAIR) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, dividends, media sentiment, valuation, profitability, institutional ownership, risk and analyst recommendations.

Retractable Technologies has higher revenue and earnings than Beyond Air. Retractable Technologies is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Retractable Technologies	$37.15M	0.59	-$7.01M	-$0.21	N/A
Beyond Air	$7.68M	0.88	-$33.25M	-$4.40	N/A

Retractable Technologies has a net margin of -41.11% compared to Beyond Air's net margin of -432.99%. Retractable Technologies' return on equity of -17.15% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Retractable Technologies	-41.11%	-17.15%	-9.33%
Beyond Air	-432.99%	-350.00%	-101.34%

Retractable Technologies has a beta of 1.22, indicating that its stock price is 22% more volatile than the broader market. Comparatively, Beyond Air has a beta of 0.22, indicating that its stock price is 78% less volatile than the broader market.

In the previous week, Retractable Technologies had 1 more articles in the media than Beyond Air. MarketBeat recorded 1 mentions for Retractable Technologies and 0 mentions for Beyond Air. Retractable Technologies' average media sentiment score of 0.00 equaled Beyond Air'saverage media sentiment score.

Company	Overall Sentiment
Retractable Technologies	Neutral
Beyond Air	Neutral

Beyond Air has a consensus price target of $10.00, suggesting a potential upside of 2,036.75%. Given Beyond Air's stronger consensus rating and higher probable upside, analysts clearly believe Beyond Air is more favorable than Retractable Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Retractable Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

7.6% of Retractable Technologies shares are owned by institutional investors. Comparatively, 31.5% of Beyond Air shares are owned by institutional investors. 59.5% of Retractable Technologies shares are owned by company insiders. Comparatively, 10.0% of Beyond Air shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Retractable Technologies beats Beyond Air on 9 of the 15 factors compared between the two stocks.

Get Beyond Air News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding XAIR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

XAIR vs. The Competition

Export

Metric	Beyond Air	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$6.74M	$3.78B	$7.16B	$12.48B
Dividend Yield	N/A	2.16%	2.66%	6.52%
P/E Ratio	-0.11	21.61	28.02	24.70
Price / Sales	0.88	340.19	540.37	99.49
Price / Cash	N/A	147.12	49.26	57.09
Price / Book	0.14	8.66	10.96	6.46
Net Income	-$33.25M	$23.81M	$3.57B	$337.01M
7 Day Performance	-5.45%	3.39%	2.12%	1.69%
1 Month Performance	13.37%	10.81%	5.25%	3.81%
1 Year Performance	-86.93%	62.61%	33.29%	23.90%

Beyond Air Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
XAIR Beyond Air	2.0689 of 5 stars	$0.47 flat	$10.00 +2,036.8%	-86.9%	$6.74M	$7.68M	N/A	70	Earnings Report
MLSS Milestone Scientific	1.2723 of 5 stars	$0.29 -2.1%	$1.00 +242.5%	-48.9%	$25.39M	$8.90M	N/A	30	Gap Up
POAI Predictive Oncology	N/A	$7.14 +0.3%	N/A	-44.6%	$24.23M	$1.66M	N/A	30	Gap Down
MODD Modular Medical	0.5627 of 5 stars	$4.53 +5.6%	N/A	-79.0%	$20.94M	N/A	N/A	20	Gap Up High Trading Volume
IRIX IRIDEX	2.6467 of 5 stars	$1.19 +0.8%	$3.00 +152.3%	+23.4%	$20.68M	$52.67M	N/A	120	News Coverage Positive News Analyst Upgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:XAIR) was last updated on 7/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Beyond Air (XAIR) Competitors

XAIR vs. MLSS, POAI, MODD, IRIX, and RVP

How does Beyond Air compare to Milestone Scientific?

Summary

How does Beyond Air compare to Predictive Oncology?

Summary

How does Beyond Air compare to Modular Medical?

Summary

How does Beyond Air compare to IRIDEX?

Summary

How does Beyond Air compare to Retractable Technologies?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

XAIR vs. The Competition

Beyond Air Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Beyond Air (XAIR) Competitors

XAIR vs. MLSS, POAI, MODD, IRIX, and RVP

How does Beyond Air compare to Milestone Scientific?

Is XAIR or MLSS more profitable?

Do insiders & institutionals believe in XAIR or MLSS?

Which has higher valuation & earnings, XAIR or MLSS?

Which has more volatility and risk, XAIR or MLSS?

Do analysts recommend XAIR or MLSS?

Does the media favor XAIR or MLSS?

Summary

How does Beyond Air compare to Predictive Oncology?

Which has preferable valuation & earnings, POAI or XAIR?

Does the media prefer POAI or XAIR?

Which has more volatility and risk, POAI or XAIR?

Do analysts recommend POAI or XAIR?

Is POAI or XAIR more profitable?

Do institutionals and insiders have more ownership in POAI or XAIR?

Summary

How does Beyond Air compare to Modular Medical?

Do insiders and institutionals hold more shares of XAIR or MODD?

Which has more risk & volatility, XAIR or MODD?

Is XAIR or MODD more profitable?

Does the media refer more to XAIR or MODD?

Do analysts recommend XAIR or MODD?

Which has higher valuation and earnings, XAIR or MODD?

Summary

How does Beyond Air compare to IRIDEX?

Is IRIX or XAIR more profitable?

Do analysts recommend IRIX or XAIR?

Which has better valuation & earnings, IRIX or XAIR?

Do institutionals & insiders hold more shares of IRIX or XAIR?

Which has more volatility & risk, IRIX or XAIR?

Does the media prefer IRIX or XAIR?

Summary

How does Beyond Air compare to Retractable Technologies?

Which has better valuation & earnings, RVP or XAIR?

Is RVP or XAIR more profitable?

Which has more volatility and risk, RVP or XAIR?

Does the media refer more to RVP or XAIR?

Do analysts prefer RVP or XAIR?

Do institutionals and insiders hold more shares of RVP or XAIR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

XAIR vs. The Competition

Beyond Air Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools